期刊文献+

Luminal A型和HER-2阳性乳腺癌的肿瘤干细胞生物学行为比较 被引量:4

Comparison of biological behaviors in cancer stem cells derived from Luminal A and HER-2-positive breast cancer
原文传递
导出
摘要 目的:比较人Luminal A型和HER-2阳性乳腺癌的肿瘤干细胞的生物学行为差异。方法:用Luminal A型和HER-2阳性乳腺癌组织培分离并培养原代乳腺癌细胞,获取富含肿瘤干细胞的微球体(MS);用胰酶将MS消化成单细胞(微球体细胞,MSDC),比较两类乳腺癌MSDC的体外增殖和自我更新能力、ALDH1+表型肿瘤干细胞含量,以及移植NOD/SCID小鼠后的成瘤情况。结果:Luminal A型和HER-2阳性乳腺癌组织分离的原代乳腺癌细胞均能培养出MS,但相对于Luminal A型乳腺癌,HER-2阳性乳腺癌来源的MS形成时间短,生成的MS体积大;HER-2阳性乳腺癌来源的MSDC无论在无血清或添加血清的培养基中的增殖与再生能力均明显强于Luminal A型乳腺癌来源的MSDC,且前者含ALDH1表型干细胞比例明显高于后者(均P<0.05);HER-2阳性乳腺癌的MSDC在NOD/SCID小鼠体内成瘤能力也强于Luminal A型乳腺癌来源的MSDC。结论:Luminal A型和HER-2阳性乳腺癌分离出来肿瘤干细胞生物学行为存在明显的差异,两者可能有不同肿瘤干细胞起源。 Objective: To compare the difference in biological behaviors between two types of tumor stem cells derived from human Luminal A and HER-2-positive breast cancer.Methods: Primary breast cancer cells were isolated from specimens of Luminal A and HER-2-positive breast cancer tissues and cultured, and then the mammospheres(MSs) were obtained, which were highly enriched in tumor stem cells. MSs were dissociated into single cells(mammospheres-derived cells, MSDCs) by trypsin digestion, and then the proliferative and regenerative abilities in vitro, the proportions of ALDH1+ cell population, and the tumor formation abilities after inoculation into NOD/SCID mice were compared betweenMSDCs from the two types of breast cancer.Results: MSs formed in the primary cultured breast cancer cells either isolated from Luminal A or HER-2-positive breast cancer tissue. However, in HER-2-positive breast cancer, the MSs formation time was shorter and their volume was larger than those in Luminal A breast cancer. The proliferative and regenerative abilities in MSDCs from HER-2-positive breast cancer were significantly higher than those in MSDCs from Luminal A breast cancer either cultured in serum-free medium or medium containing serum, and the proportion of ALDH1+ cell population in the former was significantly higher than that in the latter(all P0.05). The tumor formation ability of MSDCs from HER-2-positive breast cancer was stronger than that of MSDCs from Luminal A breast cancer in NOD/SCID mice.Conclusion: The tumor stem cells isolated from Luminal A and HER-2-positive breast cancer have significantly different biological behaviors. So the two types of breast cancer may originate from different tumor stem cells.
出处 《中国普通外科杂志》 CAS CSCD 北大核心 2017年第11期1431-1438,共8页 China Journal of General Surgery
基金 海南省卫生计生科教基金资助项目(02A2150014P1)
关键词 乳腺肿瘤 肿瘤干细胞 微球体 受体 ERBB-2 Breast Neoplasms Neoplastic Stem Cells Microspheres Receptor, ErbB-2
  • 相关文献

参考文献9

二级参考文献152

  • 1左文述,魏玲,宋现让,王兴武,王明玉,王永胜,于志勇,毕晔.浸润性乳腺癌组织中P-糖蛋白以及肺耐药蛋白和多药耐药相关蛋白表达的临床意义[J].中华医学杂志,2006,86(44):3142-3145. 被引量:9
  • 2AL-HAJJ M,WICHA M S,BENITO-HERNANDEZ A,et al.Prospective identification of tumorigenic breast cancer cells[J].PNAS,2003,100(7):3983-3988.
  • 3PONTI D,COSTA A,ZAFFARONI N,et al.Isolation and in vitro propagation of tumorigenic breast cancer cells with stem/progenitor cell properties[J].Cancer Res,2005,65 (13):5506-5511.
  • 4DONTU G,ABDALLAH W M,FOLEY J M,et al.In vitro propagation and transcriptional profiling of human mammary stem/progenitor cells[J].Genes Dev,2003,17(10):1253-1270.
  • 5CARIATI M,NADERI A,BROWN J P,et al.Alpha-6 integrin is necessary for the tumourigenicity of a stem cell-like subpopulation within the MCF7 breast cancer cell line[J].Int J Cancer,2008,122 (2):298-304.
  • 6JAMES J,DAS A V,RAHNENFHRER J,et al.Cellular and molecular characterization of early and late retinal stem cells/progenitors:differential regulation of proliferation and context dependent role of Notch signaling[J].J Neurobiol,2004,61(3):359-376.
  • 7ZHENG W,NOWAKOWSKI R S,VACCARINO F M.Fibroblast growth factor 2 is required for maintaining the neural stem cell pool in the mouse brain subventricular zone[J].Dev Neurosci,2004,26(2-4):181-196.
  • 8DEY D,SAXENA M,PARANJAPE A N,et al.Phenotypic and functional characterization of human mammary stem/progenitor cells in long term culture[J].PLoS ONE,2009,4(4):5329-5340.
  • 9ABRAHAM B K,FRITZ P,MCCLELLAN M,et al.Prevalence of CD44^+/CD24^(-/low) cells in breast cancer may not be associated with clinical outcome but may favor distant metastasis[J].Clin Cancer Res,2005,11(3):1154-1159.
  • 10PHILLIPS T M,MCBRIDE W H,PAJONK F.The response of CD24(-/low)/CD44+ breast cancer-initiating cells to radiation[J].J Natl Cancer Inst,2006,98(24):1755-1757.

共引文献55

同被引文献42

引证文献4

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部